FindTrial
Sign In

Florbetapir (18F)

DRUG8 trials

Sponsors

Institut National De La Sante Et De La Recherche Medicale, Avid Radiopharmaceuticals, University Hospital, Bordeaux

Conditions

Alcohol Use DisorderAlzheimerAlzheimer's DiseaseAlzheimer's Disease (AD) and Related DisordersLewy Body DementiaMild Cognitive ImpairmentNarcolepsyOrganic amnesia syndrome

Phase 1

A Study of Florbetapir (18F) in Japanese Healthy Volunteers
CompletedNCT01660815
Avid RadiopharmaceuticalsAlzheimer's Disease
Start: 2012-08-31End: 2013-01-31Updated: 2013-09-19
Florbetapir Calibration to the Centiloid Scale
CompletedNCT02120664
Avid RadiopharmaceuticalsAlzheimer's Disease
Start: 2014-04-30End: 2015-09-30Updated: 2017-03-09

Phase 2

A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
CompletedNCT01662882
Avid RadiopharmaceuticalsAlzheimer's Disease, Mild Cognitive Impairment
Start: 2012-10-31End: 2013-02-28Updated: 2013-09-19
CIRAANO: Multimodal exploration (including radiopharmaceuticals Amyvid® and Tauvid®) of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.
Not yet recruitingCTIS2025-523264-21-00
Institut National De La Sante Et De La Recherche MedicaleAlcohol Use Disorder, Alzheimer, Lewy Body Dementia +3
Target: 600Updated: 2026-01-23

Phase 3

Longitudinal Study of Brain Amyloid imaGing in MEMENTO
CompletedNCT02164643
University Hospital, BordeauxAlzheimer's Disease (AD) and Related Disorders
Start: 2014-06-10End: 2019-10-09Updated: 2022-02-03

Phase 4

Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
CompletedNCT01703702
Avid RadiopharmaceuticalsAlzheimer's Disease
Start: 2012-10-31End: 2015-04-30Updated: 2016-08-17
The Feasibility of Florbetapir Quantitation in Europe
CompletedNCT02107599
Avid RadiopharmaceuticalsAlzheimer's Disease
Start: 2014-03-31End: 2014-05-31Updated: 2015-07-09

Unknown Phase

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
WithdrawnNCT02029547
Avid RadiopharmaceuticalsAlzheimer's Disease
Start: 2014-10-31End: 2015-05-31Updated: 2014-10-23

Related Papers

Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort
Neurology2024-02-271 citations